{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T13:44:01Z","timestamp":1764510241967},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2003,3,1]]},"DOI":"10.1038\/sj.bmt.1703840","type":"journal-article","created":{"date-parts":[[2003,3,13]],"date-time":"2003-03-13T12:27:26Z","timestamp":1047558446000},"page":"347-351","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Low-dose or intermediate-dose cyclophosphamide plus granulocyte colony-stimulating factor for progenitor cell mobilisation in patients with multiple myeloma"],"prefix":"10.1038","volume":"31","author":[{"given":"E","family":"Jantunen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Putkonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Nousiainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T-T","family":"Pelliniemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Mahlam\u00e4ki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Remes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,3,12]]},"reference":[{"key":"BF1703840_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1056\/NEJM199607113350204","volume":"335","author":"M Attal","year":"1996","unstructured":"Attal M, Harousseau JL, Stoppa AM et al. High-dose therapy in multiple myeloma: a prospective randomized study of the Intergroupe Francais du Myelome. N Engl J Med 1996; 335: 91\u201397.","journal-title":"N Engl J Med"},{"key":"BF1703840_CR2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1182\/blood.V89.3.789","volume":"89","author":"B Barlogie","year":"1997","unstructured":"Barlogie B, Jagannath S, Vesole D et al. Superiority of tandem autologous transplantation over standard chemotherapy for previously untreated multiple myeloma. Blood 1997; 89: 789\u2013793.","journal-title":"Blood"},{"key":"BF1703840_CR3","first-page":"7","volume":"95","author":"S Lenhoff","year":"2000","unstructured":"Lenhoff S, Hjorth M, Holmberg E et al. Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population based study. Blood 2000; 95: 7\u201311.","journal-title":"Blood"},{"key":"BF1703840_CR4","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/sj.bmt.1702995","volume":"27","author":"A Gratwohl","year":"2001","unstructured":"Gratwohl A, Passweg J, Baldomero H et al. Hematopoietic stem cell transplantation activity in Europe 1999. Bone Marrow Transplant 2001; 27: 899\u2013916.","journal-title":"Bone Marrow Transplant"},{"key":"BF1703840_CR5","first-page":"11","volume":"9","author":"D Kotasek","year":"1992","unstructured":"Kotasek D, Shepherd KM, Sage RE et al. Factors affecting stem cell collections in lymphoma, myeloma and solid tumors. Bone Marrow Transplant 1992; 9: 11\u201317.","journal-title":"Bone Marrow Transplant"},{"key":"BF1703840_CR6","first-page":"49","volume":"12","author":"J-M Boiron","year":"1993","unstructured":"Boiron J-M, Marit G, Faberes C et al. Collection of peripheral blood stem cells in multiple myeloma following single high-dose cyclophosphamide with and without recombinant human granulocyte\u2013macrophage colony-stimulating factor (rhGM-CSF). Bone Marrow Transplant 1993; 12: 49\u201355.","journal-title":"Bone Marrow Transplant"},{"key":"BF1703840_CR7","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1038\/sj.leu.2401105","volume":"12","author":"G Marit","year":"1998","unstructured":"Marit G, Thiessard F, Faberes C et al. Factors affecting both peripheral blood progenitor cell mobilization and hematopoietic recovery following autologous blood progenitor cell transplantation in multiple myeloma patients: a monocentric study. Leukemia 1998; 12: 1447\u20131456.","journal-title":"Leukemia"},{"key":"BF1703840_CR8","first-page":"691","volume":"17","author":"H Goldschmidt","year":"1996","unstructured":"Goldschmidt H, Hegenbart U, Haas R, Hunstein W . Mobilization of peripheral blood progenitor cells with high-dose cyclophosphamide (4\u2009g\/m2 or 7\u2009g\/m2) and granulocyte colony-stimulating factor in patients with multiple myeloma. Bone Marrow Transplant 1996; 17: 691\u2013697.","journal-title":"Bone Marrow Transplant"},{"key":"BF1703840_CR9","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/sj.bmt.1702879","volume":"27","author":"O Fitoussi","year":"2001","unstructured":"Fitoussi O, Perreau V, Boiron JM et al. A comparison of toxicity following two different doses of cyclophosphamide for mobilization of peripheral blood progenitor cells in 116 multiple myeloma patients. Bone Marrow Transplant 2001; 27: 837\u2013842.","journal-title":"Bone Marrow Transplant"},{"key":"BF1703840_CR10","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/sj.bmt.1700938","volume":"20","author":"S Armitage","year":"1997","unstructured":"Armitage S, Hargreaves R, Samson D et al. CD34 counts to predict adequate collection of peripheral blood progenitor cells. Bone Marrow Transplant 1997; 20: 587\u2013591.","journal-title":"Bone Marrow Transplant"},{"key":"BF1703840_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1089\/scd.1.1997.6.13","volume":"6","author":"K Remes","year":"1997","unstructured":"Remes K, Matinlauri I, Grenman S et al. Daily measurements of blood CD34+ cells after stem cell mobilization predict stem cell yield and posttransplant hematopoietic recovery. J Hematother 1997; 6: 13\u201319.","journal-title":"J Hematother"},{"key":"BF1703840_CR12","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/sj.bmt.1701477","volume":"22","author":"NH Russell","year":"1998","unstructured":"Russell NH, McQuaker G, Stainer C et al. Stem cell mobilisation in lymphoproliferative diseases. Bone Marrow Transplant 1998; 22: 935\u2013940.","journal-title":"Bone Marrow Transplant"},{"key":"BF1703840_CR13","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1200\/JCO.1995.13.10.2547","volume":"13","author":"WI Bensinger","year":"1995","unstructured":"Bensinger WI, Appelbaum FR, Rowley S et al. Factors that influence collection and engraftment of autologous peripheral blood cells. J Clin Oncol 1995; 13: 2547\u20132555.","journal-title":"J Clin Oncol"},{"key":"BF1703840_CR14","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1046\/j.1365-2141.1996.448987.x","volume":"93","author":"HM Prince","year":"1996","unstructured":"Prince HM, Imrie K, Sutherland DR et al. Peripheral blood progenitor cell collections in multiple myeloma: predictors and management of inadequate collections. Br J Haematol 1996; 93: 142\u2013145.","journal-title":"Br J Haematol"},{"key":"BF1703840_CR15","first-page":"937","volume":"17","author":"T Demirer","year":"1996","unstructured":"Demirer T, Buckner CD, Gooley T et al. Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma. Bone Marrow Transplant 1996; 17: 937\u2013941.","journal-title":"Bone Marrow Transplant"},{"key":"BF1703840_CR16","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1046\/j.1365-2141.1997.2783095.x","volume":"98","author":"H Goldschmidt","year":"1997","unstructured":"Goldschmidt H, Hegenbart U, Wallmeier M et al. Factors influencing collection of peripheral blood progenitor cells following high-dose cyclophosphamide and granulocyte colony-stimulating factor in patients with multiple myeloma. Br J Haematol 1997; 98: 736\u2013744.","journal-title":"Br J Haematol"},{"key":"BF1703840_CR17","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1200\/JCO.1998.16.4.1547","volume":"16","author":"KR Desikan","year":"1998","unstructured":"Desikan KR, Barlogie B, Jagannath S et al. Comparable engraftment kinetics following peripheral blood stem-cell infusion mobilized with granulocyte colony-stimulating factor with or without cyclophosphamide in multiple myeloma. J Clin Oncol 1998; 16: 1547\u20131553.","journal-title":"J Clin Oncol"},{"key":"BF1703840_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1046\/j.1365-2141.1996.d01-1506.x","volume":"92","author":"B Mahe","year":"1996","unstructured":"Mahe B, Milpied N, Hermouet S et al. G-CSF alone mobilizes sufficient peripheral blood CD34+ cells for positive selection in newly diagnosed patients with multiple myeloma and lymphoma. Br J Haematol 1996; 92: 263\u2013268.","journal-title":"Br J Haematol"},{"key":"BF1703840_CR19","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1200\/JCO.2000.18.9.1824","volume":"18","author":"O Koc","year":"2000","unstructured":"Koc O, Gerson S, Cooper B et al. Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte\u2013macrophage colony-stimulating factor plus G-CSF. J Clin Oncol 2000; 18: 1824\u20131830.","journal-title":"J Clin Oncol"},{"key":"BF1703840_CR20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/sj.bmt.1700867","volume":"20","author":"A Alegre","year":"1997","unstructured":"Alegre A, Tomas JF, Martinez-Chamorro C et al. Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high-dose cyclophosphamide plus GM-CSF vs. G-CSF alone. Bone Marrow Transplant 1997; 20: 211\u2013217.","journal-title":"Bone Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1703840.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703840","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703840.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T23:41:58Z","timestamp":1648078918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1703840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3,1]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,3,1]]}},"alternative-id":["BF1703840"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1703840","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,3,1]]},"assertion":[{"value":"11 June 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}